Approval · Notice of Compliance 14071 · 2013
CLINDAMYCIN: Notice of Compliance 14071
Issued February 11, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14071
- Date
- February 11, 2013
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- DALACIN C CAPSULES (Pharmacia & Upjohn Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLINDAMYCIN | 02400529 | Marketed |
| CLINDAMYCIN | 02400537 | Marketed |
Medicinal ingredients
- CLINDAMYCIN HCL 150 MG per CAP
- CLINDAMYCIN HCL 300 MG per CAP